B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CBX1

MOLECULAR TARGET

chromobox 1

UniProt: P83916NCBI Gene: 1095129 compounds

CBX1 (chromobox 1) is targeted by 29 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CBX1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Disulfiram1.102
2Levodopa1.102
3piceatannol1.102
4myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
5ag4900.691
6Aurintricarboxylic Acid0.691
7Calcimycin0.691
8Cisplatin0.691
9Clotrimazole0.691
10Diamide0.691
11Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
12ethopropazine0.691
13Fluspirilene0.691
14Idarubicin0.691
15Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on0.691
16Kynurenic Acid0.691
17ly2940020.691
18Metergoline0.691
19methionine sulfoximine0.691
20Methyldopa0.691
21Nisoldipine0.691
22Oxytetracycline0.691
23Papaverine0.691
24Perphenazine0.691
25Promethazine0.691
26Reserpine0.691
27Rotenone0.691
28Nitroprusside0.691
29tyrphostin 90.691

About CBX1 as a Drug Target

CBX1 (chromobox 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 29 compounds with documented CBX1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CBX1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.